$PMCB PharmaCyte Biotech (PMCB) is locked and load
Post# of 1086
Posted On: 01/14/2016 9:16:06 PM
$PMCB PharmaCyte Biotech (PMCB) is locked and loaded -- money-wise -- for a while, funded to begin the next phase of its pancreatic cancer trial. The press release was posted this morning -- PMCB pocketed $1 million via the sale of equity, bringing its cash balance up to $3 million. That should get the company pretty far down the R&D road.
As impressive as garnering a million bucks worth of funding in this environment is, I think the real story with PMCB is the chart itself.
Some of you may recall we figured the sharp, high volume selloff from December 31st was a capitulation, and the beginning of a rebound move. We still have every reason to think that. Although the stock stalled as it approached the 50-day moving average line (purple), the 20-day line (blue) has since stepped up as a floor. It even looks like the bulls are trying to use the 20-day moving average line as something of a springboard. One good push above $0.08 could ignite another round of buying.
As impressive as garnering a million bucks worth of funding in this environment is, I think the real story with PMCB is the chart itself.
Some of you may recall we figured the sharp, high volume selloff from December 31st was a capitulation, and the beginning of a rebound move. We still have every reason to think that. Although the stock stalled as it approached the 50-day moving average line (purple), the 20-day line (blue) has since stepped up as a floor. It even looks like the bulls are trying to use the 20-day moving average line as something of a springboard. One good push above $0.08 could ignite another round of buying.
(0)
(0)PharmaCyte Biotech Inc. (PMCB) Stock Research Links
Scroll down for more posts ▼